The studies by Nakemura et al. (2013) revealed that oestrogens modulate CCND1 expression trough ERβ via increasing FBJ murine osteosarcoma viral oncogene homolog (FOS) and jun proto-oncogene (JUN) expression in prostate adenocarcinoma PC3 cell line. Here, ESR2 is linked to prostate adenocarcinoma.